Steven Belinsky
Affiliations: | University of New Mexico, Albuquerque, NM, United States |
Area:
BiochemistryGoogle:
"Steven Belinsky"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Leah C. Pulling | grad student | 2003 | Univ. of New Mexico |
| Leah A. Damiani | grad student | 2008 | Univ. of New Mexico |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tellez CS, Picchi MA, Juri D, et al. (2021) Chromatin remodeling by the histone methyltransferase EZH2 drives lung pre-malignancy and is a target for cancer prevention. Clinical Epigenetics. 13: 44 |
| Tessema M, Tassew DD, Yingling CM, et al. (2020) Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients. Lung Cancer (Amsterdam, Netherlands). 146: 189-196 |
| Kuehl PJ, Tellez CS, Grimes MJ, et al. (2020) 5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming. British Journal of Cancer |
| Wang Q, Wang P, Zhang L, et al. (2019) Epigenetic Regulation of RIP3 Suppresses Necroptosis and Increases Resistance to Chemotherapy in NonSmall Cell Lung Cancer. Translational Oncology. 13: 372-382 |
| Teneng I, Picchi MA, Leng S, et al. (2019) DNA-PKc deficiency drives pre-malignant transformation by reducing DNA repair capacity in concert with reprogramming the epigenome in human bronchial epithelial cells. Dna Repair. 79: 1-9 |
| Filipczak PT, Leng S, Tellez CS, et al. (2019) p53-suppressed oncogene TET1 prevents cellular aging in lung cancer. Cancer Research |
| Kuehl P, Tellez C, Grimes M, et al. (2019) MA17.09 5-Azacytidine Inhaled Dry Powder Formulation Profoundly Improves Pharmacokinetics and Efficacy for Lung Cancer Therapy Journal of Thoracic Oncology. 14: S319-S320 |
| Tsoyi K, Osorio JC, Chu SG, et al. (2018) Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness. American Journal of Respiratory Cell and Molecular Biology |
| Tessema M, Rossi MR, Picchi MA, et al. (2018) Common cancer-driver mutations and their association with abnormally methylated genes in lung adenocarcinoma from never-smokers. Lung Cancer (Amsterdam, Netherlands). 123: 99-106 |
| Kuehl PJ, Grimes MJ, Dubose D, et al. (2018) Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model. Drug Delivery. 25: 1127-1136 |